# DESCRIPTION

- claim priority

## BACKGROUND

- introduce genome editing
- describe CRISPR/Cas system
- explain DNA repair pathways
- discuss limitations of HDR
- introduce base editors
- describe limitations of rA1-based BEs
- motivate new BEs

## SUMMARY

- introduce APOBEC3A-Cas fusion protein
- describe C to T substitution
- highlight efficiency on GpC
- discuss mutations in A3A
- introduce Cas12a-A3A fusion protein
- describe advantages of Cas12a
- define fusion protein composition
- specify APOBEC3A mutations
- specify Cas protein options
- describe UGI composition
- specify peptide linker composition
- introduce nuclear localization sequence
- provide non-limiting examples
- introduce Cpf1-based fusion protein

## DETAILED DESCRIPTION

### Definitions

- define "a" or "an" entity
- define "polypeptide"
- define "isolated" with respect to cells and nucleic acids
- define "recombinant" as it pertains to polypeptides or polynucleotides
- define "homology" or "identity" or "similarity"
- define "sequence identity"
- define "an equivalent nucleic acid or polynucleotide"
- define "an equivalent polypeptide"
- describe hybridization reactions
- define "physiological conditions"
- define "polynucleotide sequence"
- define "polymorphism"
- define "polynucleotide" and "oligonucleotide"
- describe modifications to nucleotide structure
- define "encode" as it is applied to polynucleotides
- describe fusion proteins
- introduce apolipoprotein B mRNA editing enzyme catalytic subunit 3A (APOBEC3A)
- describe APOBEC3A variants and mutants
- provide examples of APOBEC3A sequences
- describe APOBEC3A mutations
- describe combinations of APOBEC3A mutations
- describe APOBEC3A from different species
- describe retention of cytidine deaminase activity
- describe further modifications to APOBEC3A
- describe conservative substitutions
- describe retention of cytidine deaminase activity after modification
- describe retention of tested mutations after modification
- introduce clustered regularly interspaced short palindromic repeats (CRISPR)-associated (Cas) protein
- describe fusion protein comprising APOBEC3A and Cas protein
- describe optional inclusion of uracil glycosylase inhibitor (UGI)
- define APOBEC3A and its alternatives
- define fusion protein with APOBEC3A and Cas protein
- define conservative amino acid substitution
- define Cas protein and its examples
- define Cas protein mutants
- define Cas12a nickase
- describe advantage of Cas12a over Cas9
- describe increased editing efficiency with A3A
- describe further increased editing efficiency with A3A mutations
- define fusion protein with APOBEC3A and Cas12a
- describe UGI and its function
- describe peptide linker in fusion protein
- describe arrangement of APOBEC3A, Cas protein, and UGI
- describe nuclear localization sequence
- provide examples of fusion proteins
- describe isolated polynucleotides encoding fusion proteins
- describe compositions comprising fusion proteins
- describe methods for base editing using fusion proteins
- describe contacting fusion protein and guide RNA with target polynucleotide
- describe editing of cytosine in various contexts
- describe clinical significance of fusion proteins

### EXAMPLES

- introduce base editor hA3A-nCas9-UGI
- describe C-to-T base editing efficiency
- introduce mutations Y130F and Y132D
- describe narrowed window of base editing
- introduce mutations W104A and D131Y
- describe increased efficiency of base editing
- introduce three amino acid changes
- describe narrowed editing windows
- introduce human APOBEC3A-Cas9 fusion
- describe efficient base editing in methylated regions
- motivate base editing for disease treatment
- describe CpG dinucleotide methylation hindrance
- introduce BEs for efficient C-to-T base editing
- describe plasmid construction
- describe primer sets for amplifying fragments
- describe cloning of fragments into vectors
- describe construction of sgRNA expression vectors
- describe antibodies used
- describe immunoblotting analysis
- describe cell culture and transfection
- describe dCas9-Suntag-TetCD system
- describe bisulfite sequencing analysis
- describe plasmid DNA methylation
- describe blue/white colony screening
- calculate base substitution frequencies
- overlap SNVs with pathogenic human allele sequence
- calculate BE-targetable SNVs
- subclassify BE-targetable SNVs according to 3â€² adjacent base preferences
- calculate P values
- deposit deep-sequencing data
- examine base editing efficiency of BE3
- promote DNA methylation by DNMT3
- reduce DNA methylation by TET1
- compare editing frequencies under different methylation conditions
- screen for efficient base editing in high-methylation background
- fuse Cas9 nickase with APOBEC/AID deaminases
- test BEs in E. coli-derived vector system
- compare base editing efficiencies of different BEs
- examine base editing on cytosines in GpC context
- compare editing efficiencies under different methylation conditions
- design mutations to narrow editing window
- test engineered hA3A-BE3s
- compare editing efficiencies of engineered hA3A-BE3s
- fuse UGI sequence to hA3A-BE3-Y130F and hA3A-BE3-Y132D
- test hA3A-eBE-Y130F and hA3A-eBE-Y132D
- compare editing efficiencies and product purity of hA3A-eBE-Y130F and hA3A-eBE-Y132D
- construct dCas12a-hA3A-BE expression vector
- construct gRNA expression plasmid
- transfect HEK293T cells
- analyze Sanger sequencing results using EditR
- test dCas12a-hA3A-BE in gene editing of human DYRK1A
- test dCas12a-hA3A-BE in gene editing of human SITE6
- test dCas12a-hA3A-BE in gene editing of human RUNX1
- analyze sequencing results
- discuss results
- provide scope of disclosure
- incorporate references by reference

